Yes. In our disclosures, we do provide the difference between what our food business is doing in sales and what our drug business is doing in sales.
We also provide qualitative disclosure around our segment margins. That was what I was referring to. Our food segment margins, which is the food gross margin, have been unchanged and have been flat since inflation took off.